Gastric cancer remains a leading cause of global cancer mortality. Gastric intestinal metaplasia (GIM) is a crucial precursor to gastric cancer. In 2019, several European societies published consensus guidelines on GIM management through endoscopic surveillance.1,2 These guidelines were followed by recommendations from the American Gastroenterological Association.3